The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, available pharmacologic and forensic evidence consistently places etonitazene among the most potent members of the nitazene class, while isotonitazene and protonitazene demonstrate potency exceeding that of fentanyl in many experimental systems [4, 26].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These patterns are consistent with a Tennessee study from 2019 to 2021, which reported that all nitazene‐involved biological samples contained at least one additional substance, with fentanyl being the most commonly co‐detected substance (60%) [15].”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In 2021, metonitazene accounted for 85.7% of these deaths in Tennessee, despite being less potent than other nitazenes [22].”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Corroborating these findings, a study from Tennessee found that isotonitazene was involved in 90% of nitazene‐related overdose deaths in 2020, but was subsequently displaced by metonitazene, which accounted for 86% of such deaths in 2021 [15].”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“This pattern is consistent with findings from Tennessee, where methamphetamine was co‐involved in 46% of nitazene overdose deaths [15].”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [15]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
Vandeputte, M. M., Krotulski, A. J., Walther, D., Glatfelter, G. C., Papsun, D., Walton, S. E., Logan, B. K., Baumann, M. H., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03276-4 · Cited by 80
Cited by
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
Amaducci, A., Aldy, K., Campleman, S. L., Li, S., Meyn, A., Abston, S., Culbreth, R. E., Krotulski, A., Logan, B., Wax, P., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.31264 · Cited by 84
Non-Fentanyl New Synthetic Opioids—An Update
Zawilska, J. B., Adamowicz, P., Kurpeta, M., & Wojcieszak, J. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111775 · Cited by 55
Vandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 36
Field‐portable detection of fentanyl and its analogs: A review
Crocombe, R. A., Giuntini, G., Schiering, D. W., Profeta, L. T. M., Hargreaves, M. D., Leary, P. E., Brown, C. D., & Chmura, J. W. (2023) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15355 · Cited by 35
Pardi, J., Ford, S., & Cooper, G. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad062 · Cited by 29
Metadata
- Authors
- Roberts, A., Korona-Bailey, J., & Mukhopadhyay, S.
- Affiliations
- Tennessee Department of Health (US)
- Corresponding author
- Roberts, Allison
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2022-09-16
- Volume
- 71
- Issue
- 37
- Pages
- 1196-1197
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC9484803
- OpenAlex
- W4295908374
- Cited by
- 31
- References
- 2
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 3 · 2023: 5
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- nitazenes, drug overdose, drug-related deaths
- MeSH terms
- Disease Outbreaks, Humans, Medical History Taking, Tennessee
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021. https://app.cochat.ai/papers/10.15585/mmwr.mm7137a5
- The paper
- Roberts, A., Korona-Bailey, J., & Mukhopadhyay, S. (2022). Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7137a5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.